title: A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.
abstract: Because of the dominant negative effect of mutant p53, there has been limited success with wild-type (wt) p53 cancer gene therapy. Therefore, an alternative oligomerization domain for p53 was investigated to enhance the utility of p53 for gene therapy. The tetramerization domain of p53 was substituted with the coiled-coil (CC) domain from Bcr (breakpoint cluster region). Our p53 variant (p53-CC) maintains proper nuclear localization in breast cancer cells detected via fluorescence microscopy and shows a similar expression profile of p53 target genes as wt-p53. Additionally, similar tumor suppressor activities of p53-CC and wt-p53 were detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), annexin-V, 7-aminoactinomycin D (7-AAD), and colony-forming assays. Furthermore, p53-CC was found to cause apoptosis in four different cancer cell lines, regardless of endogenous p53 status. Interestingly, the transcriptional activity of p53-CC was higher than wt-p53 in 3 different reporter gene assays. We hypothesized that the higher transcriptional activity of p53-CC over wt-p53 was due to the sequestration of wt-p53 by endogenous mutant p53 found in cancer cells. Co-immunoprecipitation revealed that wt-p53 does indeed interact with endogenous mutant p53 via its tetramerization domain, while p53-CC escapes this interaction. Therefore, we investigated the impact of the presence of a transdominant mutant p53 on tumor suppressor activities of wt-p53 and p53-CC. Overexpression of a potent mutant p53 along with wt-p53 or p53-CC revealed that, unlike wt-p53, p53-CC retains the same level of tumor suppressor activity. Finally, viral transduction of wt-p53 and p53-CC into a breast cancer cell line that harbors a tumor derived transdominant mutant p53 validated that p53-CC indeed evades sequestration and consequent transdominant inhibition by endogenous mutant p53.
authors: Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah , Salt Lake City, Utah 84112, United States.
authors: Abood
authors: A
authors: Okal
authors: Mohanad
authors: M
authors: Mossalam
authors: Karina J
authors: KJ
authors: Matissek
authors: Andrew S
authors: AS
authors: Dixon
authors: Philip J
authors: PJ
authors: Moos
authors: Carol S
authors: CS
authors: Lim
mesh_terms: D017209:Apoptosis; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism; D006801:Humans; D047468:Immunoprecipitation; D020287:In Situ Nick-End Labeling; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53
references: J Biol Chem. 2006 Mar 31;281(13):8600-6
references: 16443602
references: Blood. 1994 Sep 1;84(5):1415-20
references: 8068938
references: Cancer Res. 1995 Nov 15;55(22):5187-90
references: 7585571
references: Mol Pharm. 2013 Apr 1;10(4):1350-9
references: 23402381
references: Science. 1992 May 8;256(5058):827-30
references: 1589764
references: Br J Cancer. 2002 Oct 7;87(8):909-17
references: 12373608
references: Circ Res. 2009 Jan 2;104(1):69-78
references: 19023129
references: Mol Pharm. 2012 May 7;9(5):1449-58
references: 22380534
references: Cytometry. 1992;13(2):204-8
references: 1547670
references: J Biol Chem. 2000 May 26;275(21):16202-12
references: 10821866
references: Protein Sci. 2005 Dec;14(12):2993-3003
references: 16260757
references: J Biol Chem. 2011 Aug 5;286(31):27751-60
references: 21659527
references: Mol Cell. 2001 Mar;7(3):673-82
references: 11463391
references: Oncogene. 2004 Mar 25;23(13):2330-8
references: 14743206
references: J Biol Chem. 2003 Jul 11;278(28):25395-400
references: 12734185
references: Nat Rev Cancer. 2007 Jun;7(6):441-53
references: 17522713
references: Blood. 2010 Jul 29;116(4):603-13
references: 20430957
references: Cell. 2004 Feb 20;116(4):487-9
references: 14980216
references: Mol Cell Biol. 1999 Feb;19(2):1438-49
references: 9891077
references: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2948-53
references: 11867759
references: Cell Death Dis. 2013 Apr 04;4:e574
references: 23559009
references: Hum Gene Ther. 2005 Sep;16(9):1016-27
references: 16149900
references: Mol Cell. 2003 Mar;11(3):577-90
references: 12667443
references: Cancer J. 2011 Nov-Dec;17(6):477-86
references: 22157291
references: Cancer Cell. 2012 Dec 11;22(6):751-64
references: 23238012
references: Mol Cell Biol. 2009 May;29(10):2489-504
references: 19273598
references: Cell. 1991 Nov 1;67(3):459-68
references: 1657398
references: J Virol. 1998 Dec;72(12):9479-90
references: 9811681
references: Cancer Cell. 2007 Oct;12(4):303-12
references: 17936556
references: Nat Struct Biol. 1994 Dec;1(12):877-90
references: 7773777
references: Oncogene. 1992 Apr;7(4):743-9
references: 1565469
references: Cancer Res. 1993 Oct 1;53(19):4452-5
references: 8402611
references: Cell. 1991 May 31;65(5):765-74
references: 2040013
references: Cancer Res. 1996 Jan 1;56(1):158-63
references: 8548757
references: Oncogene. 2007 Apr 2;26(15):2145-56
references: 17401423
references: J Cell Sci. 2003 Oct 15;116(Pt 20):4077-85
references: 12972501
references: J Cell Sci. 2009 Feb 15;122(Pt 4):437-41
references: 19193868
references: EMBO J. 1998 Jun 15;17(12):3342-50
references: 9628871
references: Nat Rev Cancer. 2006 Jan;6(1):83-90
references: 16397528
references: Br J Cancer. 2009 Nov 3;101(9):1606-12
references: 19773755
references: J Mol Biol. 2004 Sep 17;342(3):801-11
references: 15342238
references: Gut. 2008 Jun;57(6):799-806
references: 18203806
references: Cell. 1993 Nov 19;75(4):817-25
references: 8242752
references: J Immunol Methods. 1995 Jul 17;184(1):39-51
references: 7622868
references: Methods Cell Biol. 1998;57:251-64
references: 9648109
references: J Pathol. 2011 Jan;223(2):116-26
references: 21125670
references: Blood. 2009 Oct 22;114(17):3629-32
references: 19710506
references: Endocr Relat Cancer. 2006 Jun;13(2):293-325
references: 16728565
references: Oncogene. 1990 Jun;5(6):893-9
references: 1694291
references: Jpn J Cancer Res. 2002 May;93(5):559-66
references: 12036452
references: Oncogene. 1991 Nov;6(11):2055-65
references: 1719467
references: Nat Struct Biol. 2002 Feb;9(2):117-20
references: 11780146
references: Biochemistry. 2005 Dec 13;44(49):16246-56
references: 16331985
references: Science. 1995 Mar 10;267(5203):1498-502
references: 7878469
references: J Control Release. 2009 Dec 16;140(3):245-9
references: 19576252
references: Oncogene. 2005 Oct 20;24(46):6976-81
references: 16007150
references: Clin Exp Metastasis. 2007;24(6):471-83
references: 17636407